Unveiling Neurological Disorder Drugs Market Industry Trends
The Neurological Disorder Drugs Market is booming, projected to reach $XX million by 2033 with a 5.60% CAGR. Driven by aging populations and rising prevalence of Alzheimer's, Parkinson's, and epilepsy, this market is segmented by drug type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, etc.) and geography. Key players include Teva, Merck, and more. Learn more about market trends and future growth.